myxofibrosarcoma

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

Recruiting
  • Sarcoma
  • +3 more
  • Isolated Limb Infusion
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 21, 2022

Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

Recruiting
  • Leiomyosarcoma
  • +29 more
  • Definitive Surgical Resection
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022

Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

Withdrawn
  • Soft Tissue Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Nov 30, 2021

Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

Withdrawn
  • Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Jul 26, 2021

Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

Unknown status
  • Sarcoma
  • +16 more
  • Sequential chemotherapy - 3 courses of AI
  • Hypofractionated radiotherapy
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021